Publication | Open Access

A dose‐ranging study evaluating the oral factor Xa inhibitor edoxaban for the prevention of venous thromboembolism in patients undergoing total knee arthroplasty

ThrombosisDose‐ranging StudyVenous ThrombosisHematologyPharmacologyPharmacotherapyVenous ThromboembolismMedicineAnticoagulant